|
|
||||||||
Published online before print December 21, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



Departments of
* Ophthalmology,
¶ Immunology, and
# Molecular Genetics and Biochemistry and
Graduate Program in Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA;
Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA;
Department of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan; and
|| Earl A. Chiles Research Institute, Providence Medical Center, Portland, Oregon, USA
1 Correspondence: Eye and Ear Institute, 203 Lothrop Street, Room 922, Pittsburgh, PA 15213, USA. E-mail: hendricksrr{at}upmc.edu
Herpes stromal keratitis (HSK) is an immunopathological disease regulated by Th1 CD4 T cells, which require APC and costimulation within the infected cornea to mediate disease. Recent studies suggest the OX40:OX40 ligand (OX40L) interaction enhances effector cell cytokine secretion at inflammatory sites. OX40+ cells were detected in HSV-1-infected mouse corneas as early as 3 days postinfection (dpi), prior to the onset of HSK, and their frequency increased through 15 dpi, when all mice exhibited severe HSK. OX40L+ cells were first detected at 7 dpi, coincident with the initiation of HSK. It is interesting that the OX40L+ cells did not coexpress MHC Class II or the dendritic cell (DC) marker CD11c. Our findings demonstrate rapid infiltration of activated (OX40+) CD4+ T cells into HSV-1-infected corneas and expression of OX40L on MHC Class II-negative cells but surprisingly, not on MHC Class II+ CD11c+ DC, which are present in the infected corneas and required for HSK. Moreover, neither local nor systemic treatment of mice with a blocking antibody to OX40L or with a blocking fusion protein altered the course of HSK significantly, possibly as a result of a lack of OX40L expression on functional APC.
Key Words: HSV-1 CD4 mouse cornea immunopathology
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |